Blog

Home » Blog

Combine treatment for moderate to high risk prostate cancer

Advanced Prostate Cancer, Radiation / By / / 1 minute of reading

Men with intermediate or high-risk localised prostate cancer should be given a combination of radical radiotherapy and androgen deprivation therapy, rather than radical radiotherapy or androgen deprivation therapy alone, recommends newly updated guidance [publications.nice.org.uk] from the National Institute of Health and Care Excellence (NICE), published today. Read the article.

Combine treatment for moderate to high risk prostate cancer Read More »

Invasive tests for prostate cancer are failing to spot the disease

Diagnosis / By / / 1 minute of reading

Thousands of men forced to have painful biopsies *  Most are still being put through outdated tests which are not reliable *  Worryingly, many get a negative result even though they have cancer *  They should be given an MRI scan that can rule the disease out Read the article.

Invasive tests for prostate cancer are failing to spot the disease Read More »

New prostate cancer treatment guidelines in UK

Decision Making / By / / 1 minute of reading

8th January 2014 – New guidance for the NHS in England on how best to diagnose and treat prostate cancer has been published by the National Institute for Health and Care Excellence (NICE). The guidance aims to ensure that men are given information about the treatment options available, even if they are not available locally, as well as help choosing the best option to suit them. Read more.

New prostate cancer treatment guidelines in UK Read More »

B2G2 component of grape seed extract induces apoptosis in prostate cancer cells

Diet, Supplements / By / / 1 minute of reading

A University of Colorado Cancer Center study published online ahead of print in the journal Nutrition and Cancer describes the laboratory synthesis of the most active component of grape seed extract, B2G2, and shows this synthesized compound induces the cell death known as apoptosis in prostate cancer cells while leaving healthy cells unharmed. Read the article.

B2G2 component of grape seed extract induces apoptosis in prostate cancer cells Read More »

Protein in prostate biopsies signals increased cancer risk

Active Surveillance, Diagnosis / By / / 1 minute of reading

Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer—among the most confusing and controversial dilemmas in health care. Read the article.

Protein in prostate biopsies signals increased cancer risk Read More »

Newsletter November 2013

Newsletters / By / / 1 minute of reading

Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: 2013 Father’s Day Walk/Run Totals Dr. Danny Vesprini and Ken Shaw – Sept.  2013 Dr. Robert Hamilton– July 2013 Our redesigned website Toronto Warriors Survivor Forum 2014 A message from our out-going chairman A message from our in-coming chairman Read it by clicking the link below to open the pdf file: November_Newsletter_2013

Newsletter November 2013 Read More »

Men (aged 40-49 years) with a single baseline PSA below 1.0 have a very low long-term risk of prostate cancer

Diagnosis / By / / 2 minutes of reading

Men (aged 40-49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: Results from a prospectively screened population cohort – Abstract [www.urotoday.com] Published on 19 November 2013 OBJECTIVE: To study the use of a baseline prostate-specific antigen (PSA) and digital rectal examination in men (aged 40-49 years) in predicting long-term prostate cancer risk in a prospectively followed, representative population cohort. PATIENTS AND METHODS: Since 1990, a random sample of men in Olmsted County (aged 40-49 years) has been followed up prospectively (n = 268), with biennial visits, including a urologic

Men (aged 40-49 years) with a single baseline PSA below 1.0 have a very low long-term risk of prostate cancer Read More »

Dairy and Prostate Cancer

Diet / By / / 1 minute of reading

“The dairy story can be confusing,” says June Chan, professor of epidemiology & biostatistics and urology at the University of California, San Francisco. She and others followed nearly 4,000 health professionals with localized prostate cancer for eight years to see which men were more likely to “progress.” Read the article.

Dairy and Prostate Cancer Read More »

Scroll to Top